World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
99
Citations
35421
World Ranking
753
National Ranking
429

Medicine

D-Index
99
Citations
35420
World Ranking
8608
National Ranking
4437

Carl F. Ware publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Carl F. Ware sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 361 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Carl F. Ware D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Carl F. Ware sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 99 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Carl F. Ware is affiliated with the Discovery Institute in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with notable contributions to subfields such as Immunology, Oncology, Epidemiology, Infectious Diseases, and Surgery.

The scientist's body of work emphasizes topics including Immune Cell Function and Interaction, Immune Response and Inflammation, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Herpesvirus Infections and Treatments, and the Long-Term Effects of COVID-19.

Recent publications include:

  • Group 3 Innate Lymphoid Cells Program a Distinct Subset of IL-22BP-Producing Dendritic Cells Demarcating Solitary Intestinal Lymphoid Tissues (2020, Immunity)
  • Realigning the LIGHT signaling network to control dysregulated inflammation (2022, The Journal of Experimental Medicine)
  • RETRACTED ARTICLE: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma (2020, Nature Neuroscience)
  • Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer (2024, Nature Reviews Drug Discovery)
  • Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS (2020, mSphere)

Frequent co-authors in Carl F. Ware's research include Richard Virgen-Slane, Paula S. Norris, Garry A. Neil, Wai Lin, and John R. Šedý, with collaborations ranging from five to six joint publications each.

Their works have been published extensively in venues such as The Journal of Immunology, bioRxiv (Cold Spring Harbor Laboratory), The Journal of Experimental Medicine, Cancer Research, and Nature Neuroscience.

Best Publications

  • Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas

    Thomas Brunner;Rona J. Mogil;Drake LaFace;Nam Jin Yoo

  • The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

    George Mosialos;Mark Birkenbacht;Ramana Yalamanchill;Todd Van Arsdale

  • The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways

    Emmanuel Dejardin;Nathalie M Droin;Mireille Delhase;Elvira Haas

  • LIGHT, a New Member of the TNF Superfamily, and Lymphotoxin α Are Ligands for Herpesvirus Entry Mediator

    Davide N Mauri;Reinhard Ebner;Rebecca I Montgomery;Kristine D Kochel

  • Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3.

    Francisco Sanchez-Madrid;Alan M. Krensky;Carl F. Ware;Elizabeth Robbins

  • Rapid colormetric assay for cell viability: Application to the quantitation of cytotoxic and growth inhibitory lymphokines

    Lora M. Green;Jeanne L. Reade;Carl F. Ware

  • B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.

    John R Sedy;Maya Gavrieli;Karen G Potter;Michelle A Hurchla

  • Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface

    Jeffrey L. Browning;Apinya Ngam-ek;Pornsri Lawton;Janice DeMarinis

  • Regulated Expression of Nuclear Receptor RORγt Confers Distinct Functional Fates to NK Cell Receptor-Expressing RORγt+ Innate Lymphocytes

    Cedric Vonarbourg;Arthur Mortha;Viet L. Bui;Viet L. Bui;Pedro P. Hernandez;Pedro P. Hernandez

  • NETWORK COMMUNICATIONS: Lymphotoxins, LIGHT, and TNF

    Carl F. Ware

  • A lymphotoxin-β-specific receptor

    Paul D. Crowe;Todd L. VanArsdale;Barbara N. Walter;Carl F. Ware

  • To kill or be killed: viral evasion of apoptosis

    Chris A. Benedict;Paula S. Norris;Carl F. Ware

  • Clinical targeting of the TNF and TNFR superfamilies

    Michael Croft;Chris A. Benedict;Carl F. Ware

  • Hepatitis C Virus Core Protein Binds to the Cytoplasmic Domain of Tumor Necrosis Factor (TNF) Receptor 1 and Enhances TNF-Induced Apoptosis

    Nongliao Zhu;Ali Khoshnan;Robert Schneider;Masayuki Matsumoto

  • A fourth IκB protein within the NF-κB signaling module

    Soumen Basak;Hana Kim;Jeffrey D. Kearns;Vinay Tergaonkar

  • The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses

    Lindsay K. Ward-Kavanagh;Wai Wai Lin;John R. Šedý;Carl F. Ware

  • TRAF5, an Activator of NF-κB and Putative Signal Transducer for the Lymphotoxin-β Receptor

    Hiroyasu Nakano;Hideo Oshima;Winston Chung;Laura Williams-Abbott

  • A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes.

    Monika A Niewczas;Monika A Niewczas;Meda E Pavkov;Jan Skupien;Jan Skupien;Adam Smiles

  • The ligands and receptors of the lymphotoxin system.

    C. F. Ware;T. L. VanArsdale;P. D. Crowe;J. L. Browning

  • Intrinsic Lymphotoxin-β Receptor Requirement for Homeostasis of Lymphoid Tissue Dendritic Cells

    Kenji Kabashima;Theresa A. Banks;K. Mark Ansel;Theresa T. Lu

  • CD27, a Member of the Tumor Necrosis Factor Receptor Superfamily, Activates NF-κB and Stress-activated Protein Kinase/c-Jun N-terminal Kinase via TRAF2, TRAF5, and NF-κB-inducing Kinase *

    Hisaya Akiba;Hiroyasu Nakano;Shigeyuki Nishinaka;Masahisa Shindo

Frequent Co-Authors

Chris A. Benedict
Chris A. Benedict La Jolla Institute For Allergy & Immunology
Michael Croft
Michael Croft La Jolla Institute For Allergy & Immunology
Klaus Pfeffer
Klaus Pfeffer Heinrich Heine University Düsseldorf
Mitchell Kronenberg
Mitchell Kronenberg University of California, San Diego
Jeffrey L. Browning
Jeffrey L. Browning Boston University
Kenneth M. Murphy
Kenneth M. Murphy Washington University in St. Louis
Dirk Elewaut
Dirk Elewaut Ghent University
Sergei A. Nedospasov
Sergei A. Nedospasov Lomonosov Moscow State University
Patricia G. Spear
Patricia G. Spear Northwestern University
Douglas R. Green
Douglas R. Green St. Jude Children's Research Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers. For those interested in advancing clinical practice alongside immunology knowledge, there are several related online degree options worth exploring. Nursing pathways, in particular, offer flexible routes to enter healthcare professions linked to immunology and patient care.

Many students opt for accelerated programs to quickly enter the workforce. For instance, some of the easiest absn program to get into options provide streamlined admission processes, allowing students to fast-track their Bachelor of Science in Nursing degrees while gaining foundational knowledge relevant to immunological health concerns.

For those starting with fewer prerequisites, there are lpn programs with easiest admission requirements that prepare students for practical nursing roles. These programs serve as entry points to healthcare careers where immunology concepts can be applied in patient care settings.

Advanced practice nursing is another related pathway. The what is the easiest np program guide highlights accessible programs for becoming Nurse Practitioners, which can include immunology-focused specialties, strengthening clinical expertise in immune-related diseases.

Specializing further, those interested in mental health applications linked to immunological factors may consider top mental health nursing programs. The best online psychiatric mental health nurse practitioner programs offer valuable training and clinical placements, bridging immunological research with psychiatric care.

Best Scientists Citing Carl F. Ware

Trending Scientists

Recently Published Articles